USANA
April 22, 2025
SALT LAKE CITY, April 22, 2025 --
USANA Health Sciences reported first-quarter 2025 net sales of 250 million dollars, up 10 percent from 228 million dollars a year earlier and up 12 percent in constant currency, as its Hiya children's health business contributed 37 million dollars. Net earnings fell to 9.4 million dollars, or 0.49 dollars per diluted share, from 16.5 million dollars, or 0.86 dollars. Adjusted earnings were 0.73 dollars per share and adjusted EBITDA was 30 million dollars, compared with 33 million dollars.
The core direct selling business remained under pressure, with active customers falling to 459,000 from 494,000. Asia Pacific sales fell 6 percent to 174 million dollars, including a 7 percent decline in Greater China to 119 million dollars, while the Americas and Europe fell 9 percent to 39 million dollars. Hiya ended the quarter with 224,000 active monthly subscribers.
The company reiterated its 2025 outlook for net sales of 920 million dollars to 1.0 billion dollars, earnings of 1.50 to 2.20 dollars per share and adjusted EBITDA of 107 million to 123 million dollars, excluding any potential tariff effects. President and Chief Executive Jim Brown said direct selling net sales and active customers grew modestly on a sequential basis for the second straight quarter. USANA ended the quarter with 180 million dollars in cash and 23 million dollars of debt and repurchased 399,000 shares for 12 million dollars.